Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
DENTSPLY SIRONA Inc (XRAY)
NASDAQ:XRAY
Holding XRAY?
Track your performance easily
XRAY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$17.21 - $36.63
Previous CloseN/A
Volume461.38K
Average Volume (3M)2.85M
Market Cap
$3.67B
Enterprise Value$7.46B
Total Cash (Recent Filing)$383.90M
Total Debt (Recent Filing)$1.51B
Price to Earnings (P/E)―
Beta0.41
Next Earnings
Feb 26, 2025EPS Estimate
0.43Last Dividend Ex-Date
Dec 27, 2024Dividend Yield3.51%
Share Statistics
EPS (TTM)-2.07
Shares Outstanding198,779,570
10 Day Avg. Volume2,675,495
30 Day Avg. Volume2,847,084
Standard Deviation0.09
R-Squared0.31
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.93
Price to Cash Flow (P/CF)6.40
P/FCF Ratio9.30
Enterprise Value/Market Cap2.04
Enterprise Value/Revenue1.92
Enterprise Value/Gross Profit3.58
Enterprise Value/Ebitda-30.09
Forecast
1Y Price Target
$23.18Price Target Upside25.70% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
DENTSPLY SIRONA News
PremiumCompany Announcements
DENTSPLY SIRONA Discusses Byte Strategy at Conference
Bulls Say, Bears Say
Bulls Say
Financial PerformanceXRAY provided preliminary 3Q24 results with sales above expectations and adjusted EPS range higher than predicted.
Product DevelopmentPrimary catalysts for XRAY include potential for a quicker-than-expected rebound of the dental equipment market and better-than-expected PrimeScan 2 sales growth.
ValuationXRAY's valuation is viewed as pricing in overly negative expectations, suggesting potential for reassessment.
Bears Say
Financial PerformanceThe stranded cost burden from the Byte suspension and subdued revenue growth will likely impact operating profits.
Market ChallengesByte is entering a competitive market where relationships with dentists and orthodontists are incredibly important.
Regulatory InvestigationThe disclosure that federal and local authorities, along with tax investigators, arrived at XRAY's main German offices raised concerns.
---
Ownership Overview
0.54% Insiders
43.34% Mutual Funds
0.18% Other Institutional Investors
33.34% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
XRAY FAQ
What was DENTSPLY SIRONA Inc’s price range in the past 12 months?
DENTSPLY SIRONA Inc lowest stock price was $17.21 and its highest was $36.63 in the past 12 months.
What is DENTSPLY SIRONA Inc’s market cap?
DENTSPLY SIRONA Inc’s market cap is $3.67B.
When is DENTSPLY SIRONA Inc’s upcoming earnings report date?
DENTSPLY SIRONA Inc’s upcoming earnings report date is Feb 26, 2025 which is in 39 days.
How were DENTSPLY SIRONA Inc’s earnings last quarter?
DENTSPLY SIRONA Inc released its earnings results on Nov 07, 2024. The company reported $0.5 earnings per share for the quarter, beating the consensus estimate of $0.474 by $0.026.
Is DENTSPLY SIRONA Inc overvalued?
According to Wall Street analysts DENTSPLY SIRONA Inc’s price is currently Undervalued.
Does DENTSPLY SIRONA Inc pay dividends?
DENTSPLY SIRONA Inc pays a Quarterly dividend of $0.617 which represents an annual dividend yield of 3.51%. See more information on DENTSPLY SIRONA Inc dividends here
What is DENTSPLY SIRONA Inc’s EPS estimate?
DENTSPLY SIRONA Inc’s EPS estimate is 0.43.
How many shares outstanding does DENTSPLY SIRONA Inc have?
DENTSPLY SIRONA Inc has 198,779,570 shares outstanding.
What happened to DENTSPLY SIRONA Inc’s price movement after its last earnings report?
DENTSPLY SIRONA Inc reported an EPS of $0.5 in its last earnings report, beating expectations of $0.474. Following the earnings report the stock price went down -28.007%.
Which hedge fund is a major shareholder of DENTSPLY SIRONA Inc?
Currently, no hedge funds are holding shares in XRAY
---
DENTSPLY SIRONA Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$23.18 (25.70% Upside)
$23.18 (25.70% Upside)
Blogger Sentiment
Bullish
XRAY Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 1.6M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $310.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▲ 3.3%
Last 30 Days ▼ 4.7%
Last 30 Days ▼ 4.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-47.36%
12-Months-Change
Fundamentals
Return on Equity
-14.08%
Trailing 12-Months
Asset Growth
-7.99%
Trailing 12-Months
Company Description
DENTSPLY SIRONA Inc
DENTSPLY SIRONA, Inc. engages in the design, manufacture, sales, and distribution of professional dental products and technologies. It operates through the Technologies and Equipment, and Consumables segments. The Technologies and Equipment segments comprises dental technology, equipment, and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers, and consumable medical device products. The Consumables segment offers preventive, restorative, instruments, endodontic, and orthodontic dental products. The company was founded in 2016 and is headquartered in York, PA.
---
XRAY Company Deck
---
XRAY Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with significant achievements in digital innovation and operational efficiencies, such as the Primescan 2 launch and ERP deployment. However, these were overshadowed by regulatory issues and financial challenges, notably with Byte, leading to a cautious outlook. The sentiment is cautious due to the balance of positive innovations against substantial operational and market pressures.Read More>---
XRAY Net sales Breakdown
37.02% Essential Dental Solutions
29.48% Connected Technology Solutions
26.23% Orthodontic and Implant Solutions
7.26% Wellspect Healthcare
---
XRAY Stock 12 Month Forecast
Average Price Target
$23.18
▲(25.70% Upside)
Technical Analysis
Align Tech
―
Henry Schein
―
Zimmer Biomet Holdings
―
Smith & Nephew Snats
―
Medtronic
―
Edwards Lifesciences
―
Best Analysts Covering XRAY
1 Year
1 Year Success Rate
11/20 ratings generated profit
1 Year Average Return
-0.41%
reiterated a buy rating 11 months ago
Copying Brandon Couillard's trades and holding each position for 1 Year would result in 55.00% of your transactions generating a profit, with an average return of -0.41% per trade.
---